Skip to main content
Premium Trial:

Request an Annual Quote

Lab-on-a-Chip Technology Poised for Broad Market Growth

NEW YORK, Jan. 14 — Lab-on-a-chip technology "will have a major impact on the multi-billion dollar analytical laboratory instrumentation marketplace," says a report released on Monday.

 

According to the Frost & Sullivan report, proteomics, medical diagnostics, and pathogen identification are driving product development, which has moved lab-on-a-chip techniques from the theoretical realm to the marketplace.

 

The report, the fourth update of a paper first published in 1999, points to the continued standardization and development of DNA and protein microarrays, and the recent emergence of the multi-function chips.

 

While just a few years ago the prospects of an integrated microfluidics chip was uncertain, the benefits of combining these functions are now clearer and the technology more manageable, according to the report.

 

"The outlook for labs-on-a-chip is optimistic, although there are many hurdles to overcome," the authors write.

 

The report points to future life-science applications like point-of-care testing at the bedside, battlefield, or ambulance; on-site environmental sampling of soil, water, and air specimens; and use in production lines for foods, cosmetics, and the pharmaceutical industry.

 

The report was produced by Technical Insights, a business unit of Frost & Sullivan. It covers single-function and microarray-type labs-on-a-chip, as well as current work to develop "total microanalytical system" devices.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.